BioAge Labs, Inc (BIOA) — Strategic Asset Allocation Index
BioAge Labs, Inc (BIOA) has a Strategic Asset Allocation Index of 3.7% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $10.18 Million) total $10.18 Million, measured against net assets of $277.46 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check financial resilience of BioAge Labs, Inc to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
BioAge Labs, Inc Strategic Asset Allocation Index (2024–2024)
This chart shows how BioAge Labs, Inc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2024 to 2024. As of September 2025, the index stands at 3.7%, representing strategic assets of $10.18 Million against net assets of $277.46 Million USD. See financial agility of BioAge Labs, Inc to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for BioAge Labs, Inc (2024–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for BioAge Labs, Inc from 2024 to 2024, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see BIOA market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.0% | $100.00K | $- | $100.00K | $323.13 Million | — |